Author details

Full Name

Deborah C Molrine

Affiliation

ORCID

Career Start Year

1993

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
35746504	Review of Analyses Estimating Relative Vaccine Effectiveness of Cell-Based Quadrivalent Influenza Vaccine in Three Consecutive US Influenza Seasons.	Vaccines	2022
36298465	Outcomes in Pregnant Persons Immunized with a Cell-Based Quadrivalent Inactivated Influenza Vaccine: A Prospective Observational Cohort Study.	Vaccines	2022
36214072	Safety and Immunogenicity of Cell-Based Quadrivalent Influenza Vaccine: A Randomized Trial.	Pediatrics	2022
32507409	Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.	Vaccine	2020
29020321	Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study.	Clinical Infectious Diseases	2018
28127942	Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study.	J Viral Hepat	2017
28933665	Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria.	Human Vaccines and Immunotherapeutics	2017
27070129	Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model.	Virulence	2016
27365387	Antibodies to Toxin B Are Protective Against Clostridium difficile Infection Recurrence.	Clin Infect Dis	2016
26042465	Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia.	International Journal of Molecular Sciences	2015
24956119	High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.	PLoS One	2014
23356386	Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.	Am J Transplant	2013
23010601	Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults.	Vaccine	2012
22952447	Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees.	PLoS Pathogens	2012
20089970	Treatment with monoclonal antibodies against Clostridium difficile toxins.	New England Journal of Medicine	2010
19941990	Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).	Vaccine	2010
18502001	Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.	Vaccine	2008
16966409	Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.	Infection and Immunity	2006
15744240	Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.	Biology of Blood and Marrow Transplantation	2005
12603698	Recommendations for immunizations in stem cell transplantation.	Pediatric Transplantation	2003
12393732	Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.	Blood	2003
12399193	Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.	Vaccine	2002
11301820	Vaccines for transplant recipients.	Infectious Disease Clinics of North America	2001
11598040	Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines.	Infection and Immunity	2001
10720547	Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.	Journal of Infectious Diseases	2000
10618539	Primary respiratory syncytial virus infection: pathology, immune response, and evaluation of vaccine challenge strains in a new mouse model.	Vaccine	2000
9878041	Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients.	Journal of Infectious Diseases	1999
9827969	Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation.	Bone Marrow Transplantation	1998
9709721	Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease.	Journal of Pediatrics	1998
9232253	Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).	Bone Marrow Transplantation	1997
8537671	Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease.	J Infect Dis	1996
8807128	Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation.	Bone Marrow Transplantation	1996
8639924	Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation.	Blood	1996
7622207	Impaired human responses to tetanus toxoid in vitamin A-deficient SCID mice reconstituted with human peripheral blood lymphocytes.	Infection and Immunity	1995
7486464	Antibody responses to polysaccharide and polysaccharide-conjugate vaccines after treatment of Hodgkin disease.	Ann Intern Med	1995
8140632	Polysaccharide conjugate vaccine responses in bone marrow transplant patients.	Transplantation	1994
8226564	Critical appraisal of immunization strategies for prevention of infection in the compromised host.	Hematology/Oncology Clinics of North America	1993